What Impact is Lead-Time Reduction Having on the End-to-End Pharma Supply Chain?
Add bookmark
What Impact is Lead-Time Reduction Having on the End-to-End Pharma Supply Chain?
Add bookmark
Antoine du Sartel, Director of Global Supply Chain at Merck Serono, speaks to Andrea charles from Pharma IQ, about the impact lead-time reduction is having on the end-to-end pharma supply chain and the steps we should take to ensure end-to-end supply chain optimisation. He also shares his top 3 tips for preparing the supply chain to respond to a dynamic market and insights on how to identify the KPIs necessary to support increased effectiveness in your supply chain.&nb...
Tags:
Antoine Du Sartel
end-to-end supply chain
pharma supply chain
lead-time
KPIs
end-to-end supply chain optimisation
Merck Serono
flexible supply chain
agile supply chain
